Benzinga | Aug 3, 2021 04:32PM EDT

Apollo Endosurgery Q2 EPS $(0.11) Beats $(0.20) Estimate, Sales $16.61M Beat $13.67M Estimate

Apollo Endosurgery (NASDAQ:APEN) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.20) by 45 percent. This is a 63.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $16.61 million which beat the analyst consensus estimate of $13.67 million by 21.51 percent. This is a 194.29 percent increase over sales of $5.64 million the same period last year.